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Objective: The main goal of the present study is to investigate the effects of retinoic acid and fibroblast
growth factor-2 on serum levels of FSH and LH, histology, and apoptosis in the mouse model of Poly
Cystic Ovary Syndrome (PCOS).
Materials and methods: 80 female NMRI mice have been randomly divided into eight groups. Group 1
received normal saline as a control, and Group 2 received estradiol valerate (EV) at 4 mg/100 g of body
weight. Moreover, Groups 3e4 were administered with RA (a dose of 0.05 mg/ml) and FGF2 (a dose of
0.01 mg/kg), respectively. Groups 5 and 6 respectively received the EV plus the RA (0.05 mg/ml) and FGF2
(0.01 mg/kg). Group 7 received the RA and FGF2 at doses corresponding to healthy mice, and Group 8
received the EV plus the RA þ FGF2 (similar to previous doses). RA and FGF2 were injected three times
per week for four weeks. Finally, histological and immunohistological parameters of the ovary were
evaluated.
Results: The study revealed that both single and combined injection of fibroblast growth factor-2 (FGF2)
and retinoic acid (RA) in groups 5, 6, and 8 significantly reduced follicular diameters compared to group
2. Measurements confirmed that simultaneous injection of RA and FGF2 into polycystic mice significantly
increased antral follicles, corpus luteum (CL), epithelial thickness, and oocyte diameter as well as
decreased cystic follicles. Positive TUNEL cells that were considerably increased in the antral follicle of
group 2 significantly decreased in the RA and FGF2 recipient groups, either alone or in combination.
Besides, the injection of FGF2 increased preantral follicles and CL.
Conclusion: The findings of the present investigation reveal that injection of RA and FGF2 has both
protective and ameliorative effects that can promise new therapies for women with PCOS.
© 2020 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Poly Cystic Ovarian Syndrome (PCOS) is known to be the main
reason for infertility in women (20% of couples with infertility) [1].
Andrology symptoms of PCOS include: menstrual disordersmadi).
Gynecology. Publishing services b(Oligomenorrhea and Amenorrhea), follicle-stimulating hormone
(FSH) and decreased or increased secretion of luteinizing hormone
(LH), histological abnormalities include bilateral enlargement of
the ovary (approximately more than 10 mm), increase in ovarian
follicles with small diameter (approximately 10 mm) around the
stroma, enlarged follicle overhang and ovarian stroma and conse-
quently reduced (or no) ovulation and infertility [2]. In PCOS pa-
tients, ovulation failure occurs at the time of ovulation. In ovulation
of the PCOS patients, matrix metallopeptidases (MMPs) that breaky Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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as in response to androgen uptake or an increase in testosterone
production. MMPs are types of proteolytic enzymes that have sig-
nificant responsibility for remodeling the extracellular matrix
during ovarian follicular growth as well as ovulation. RA regulated
morphogenesis of ovarian tissue through MMPs expression [3].
MMP2 activity is significantly reduced, and LOX activity is
increased, thereby inhibiting collagen digestion and follicle
rupture, leading to non-ovulation in these patients [4].
Retinoids are a group of small organic molecules that play a
critical role in some developmental and biological processes,
including morphogenesis, growth, and cell differentiation [5].
Vitamin A deficiency can lead to a wide range of reproductive
disorders in various species, such as ovarian and testicular size
decline [6]. Studies on rats have shown that vitamin A deficiency in
the diet during pregnancy leads to placental apoptosis [7]. Some
studies have shown that retinol prevents fetal atrophy if retinol is
injected into the rat model with vitamin A deficiency before 10 days
of pregnancy [8].
Fibroblast growth factor-2 (FGF-2) is a factor involved in para-
crine signaling inside the follicle. The fibroblast growth factor is a
group of specific heparin-binding polypeptides that takes a leading
role in the development, cell growth, tissue repair, and transport. In
some in-vitro investigations, it has been indicated that FGF-2
improved proliferation of theca cells and granulosa and the
growth of primordial and primary follicles. The differentiation of
ovarian granulosa cells was performed by fibroblast growth factor
[9] through the expression of luteinizing hormone (LH) receptors
within granulosa cells and proliferating ovarian germ cells [10].
Fibroblast growth factor-2 (FGF2) contributes to the regulation of a
significant number of ovarian functions such as granulosa cell
mitosis [11] and granulosa cell differentiation and apoptosis [12].
Many studies show that adding 5 ng/ml of FGF2 to the embryonic
stem cell culture medium increases the expression level of genes
involved in pluripotency in cells [13]. Zhang et al. (2012) added 0.5,
5 and 50 ng/ml (ng/ml) FGF2 to primary bovine follicles and their
results revealed that adding different doses of FGF2 to the IVM
medium of primary bovine follicles increased the secondary oocyte,
decreased apoptosis of follicular granulosa cells and increased
blastocyst formation at day seven after IVF [14]. An investigation by
Tahaei et al. (2011) indicated that adding 2 ml of retinoic acid to the
culture medium of primary follicles increased the maturation rate
of these follicles and the percentage of oocyte maturation, and also
increased the number of blastocysts fertilized [15]. Pu et al. (2014)
indicated that 10 and 100 nmol/L of all-trans retinoic acid (ATRA)
improved oocyte survival and nuclear maturation compared to
controls. The researchers reported that ATRA inhibits apoptosis in
cumulus cells by increasing the expression of Bcl-2 and catalase
(CAT) genes and decreasing caspase-8 expression [16]. Hence, the
assumption is that administrating RA and FGF2 is probably an
efficient and excellent alternative in the survival and follicular
development in ovarian tissue and improving PCOS induction by
estradiol valerate. For this purpose, both immunohistochemistry
and histological investigations of apoptosis in granulosa cells of
ovarian follicles have been conducted to study and compare the
morphology of follicles pre- and post-treatment for four weeks in
the existence or non-existence of RA, FGF2 or the association of RA
and FGF2.
Materials and methods
Animals
Eighty immature female NMRI mice aged four weeks (Pasteur
Institute, Tehran, Iran) weighing 20 g were used. The mice were883preserved under 25 C ambient temperature, 50% humidity, and a
daily rhythmic lightedark cycle.
All mice were allowed ad libitum and water access. Ethics
Committee of Shahrekord University of Medical Sciences (Ethic
number IR. SKUMS. REC. 1397. 098) approved all procedures in the
present study.
Experimental design
Female mice have been divided into eight groups randomly (10
mice in each group):
Group1 (Normal Control): Received normal saline only.
Group2 (Positive Control): Only estradiol valerate is given.
Group3 (RA Control Group): Only injection of RA at a dose of
0.05 mg/ml.
Group4 (FGF2 Control Group): Only injection of FGF2 at a dose of
0.01 mg/kg.
Group5 (RA Intervention Group): RA injection at a dose of
0.05 mg/ml to mice induced PCOS.
Group6 (FGF2 Intervention Group): Injection of FGF2 at a dose of
0.01 mg/kg to mice induced PCOS.
Group7 (RA þ FGF2 Control group): Simultaneous injection of
RA and FGF2 at doses corresponding to healthy mice.
Group8 (RAþ FGF2 Intervention group): Simultaneous injection
of RA and FGF2 at doses corresponding to PCOS-induced mice.
Ovarian phase synchrony
Male vasectomized mice were housed in female cages for three
days to cross-cycle the mice. In order to obtain a smear, a cotton
swab dipped in saline with circular motions was drawn on the
vaginal wall. The sample was then put on the slide and fixed with
96% alcohol for 20 min. The slides were exposed to air to dry and
finally stained using the Papanicolaou method.
Induction method of PCOS
In order to induce the phenotype of PCOS, animals were treated
subcutaneously for 20 days with a daily injection of 4 mg/kg
estradiol valerate (Aburaihan Pharmaceutical Co., Tehran, Iran),
which was dissolved in sesame oil and normal saline (0.9%) [17]. In
order to confirm the induction of PCOS, after 60 days, three mice
were sacrificed, and the ovaries were removed from the oviduct
and placed in a container containing PBS solution. Excess fats were
carefully removed without damage to the ovarian tissue under the
loop, and the ovaries were inserted into the paraformaldehyde
fixative for histopathology [18].
Administration of RA and FGF2
RA was dissolved in dimethyl sulfoxide (DMSO) then the
amount of 0.05 mg/ml body weight was injected intraperitoneally
three times weekly for four weeks [19]. FGF2 was dissolved in sa-
line (0.9%) [20] and injected intraperitoneally at a dose of 0.01 mg/ml
three times each week for four weeks [21].
Measuring sex hormones
In order to assess FSH and LH levels on the day following the last
injection and overnight fasting, animals were anesthetized with
ether, then 2 ml of blood was collected from the heart with an in-
sulin syringe and transported to clot activator separation gel tube.
Then samples have been centrifuged at 3000 rpm for five minutes,
and serum was separated. Thereafter, the level of LH and FSH
measured mouse LH using standard enzyme-linked
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Germany, catalog no.: ABIN415551) and mouse FSH ELISA Kit (an-
tibodies-online; Aachen, Germany, catalog no.: ABIN1873388)
respectively. 50 mL of serum was added to each well. 50 mL of
detection reagent A added to wells immediately and placed on a
plate shaker. Furthermore, the wells were incubated for 1 h at 37 C
and aspirate all wells, as well as plate, washed three times.100 mL of
detection reagent B added and incubated for 30 min at 37 C and
five times washed. After adding a 90 mL substrate solution, thewells
were incubated 20 min at 37 C. Thereafter adding 50 mL of stop
solution to wells was readied by ELISA reader at 450 nm immedi-
ately [22].
Histological examination
The mice ovaries were removed aseptically as well as washed
with sterile PBS for histological examination. After samples were
soaked in 4% paraformaldehyde (Sigma, St. Louis, MO, USA) over-
night, then were dehydrated in different ascending concentrations
of ethanol (at 2% concentration it was done twice, but at 100%
concentration two consecutive times were performed) manually. In
the following, tissues clarified with xylene, embedded in paraffin,
and cut into 5 mm-thick sections with a rotary microtome (Leica,
Wetzlar, Germany). Tissue areas have been stained with common
hematoxylin-eosin (SigmaeAldrich; Merck KGaA) andwere cleared
with xylene. Afterward, sections were observed under light mi-
croscopy (Olympus, Tokyo, Japan) with 100 magnification, and
the number of follicles counted in different groups. In order to
evaluate ovarian tissue changes, the structures in the ovary were
morphologically divided into six groups, according to the Sun
(2015) method [23]. The follicular stages were classified as follows:
1) Primordial follicles, 2) Primary follicles, 3) Secondary or pre-
antral follicles, 4) Graffian or antral follicles, 5) Cystic follicles, and
6) Corpus luteum (CL).
Morphometrical assessment
The specimens were examined under a microscope, and follic-
ular diameter (mm), oocyte diameter (mm), theca thickness (mm),
ovarian volume (mm3), and epithelium thickness (mm) were
measured with ImageJ software (National Institutes of Health,
Bethesda, Maryland, USA) [24].
Evaluation of apoptosis by TUNEL assay
For proving apoptosis in individual cells, the apoptosis kit (Cell
Death Detection Kit; POD, Roche, Germany) was used applying the
TdT mediated dUTP nick end labeling (TUNEL) assay. The approach
is a key indicator extensively used for the assessment of apoptosis-
induced DNA fragmentation. After the paraffin-embedded block of
ovarian tissue in all groups, 5-mm serially sections were prepared.
These slices were mounted on poly-L-lysine-coated glass slides and
also deparaffinized and rehydrated using descending ethanol con-
centrations and distilled water. In order to confirm the accuracy of
the positive control samples, the microwave irradiation (MW)
pretreatment method was used before enzymatic labeling. In this
method, tissue sections are placed in a 700 W oven for 10 min. In
order to block the endogenous peroxidase before enzymatic la-
beling, slices were incubated in PBS containing 3% hydrogen
peroxide (H2O2) for 10 min. Then, the sections have been incubated
with TUNEL reaction solution containing terminal deoxy-
nucleotidyl transferase (TdT) as well as fluorescein-dUTP for
60min at 37 C. Then, the sections have beenwashed three times in
PBS solution and incubated with anti-fluorescence antibody con-
jugated with peroxidase (Roche Applied Science, Mannheim,884Germany) at 37 C for 30 min. Afterward, the sections have been
washed again in PBS solution three times and stained with chro-
mogen 3,30-diaminobenzidine tetrahydrochloride (DAB;
SigmaeAldrich, Germany) [25]. The average number of apoptotic
cells that turned brown was calculated by ImageJ software [26]. In
all groups, antral follicles and primary oocytes inside them were
used to measure the diameter and thickness as well as to evaluate
cell apoptosis.
Data analysis
The authors imported the data into SPSS version 20. The vari-
ables in the study groups were compared using one-way ANOVA
with Tukey post hoc test, and P-value less than 0.05 was considered
as significant.
Results
Verification of the PCOS mice model
The successful induction of syndrome after 20 days of induction
has been investigated using light microscopy for assessing the an-
imals' estrus cyclicity with regard to the vaginal epithelial cell
smears. Moreover, a number of the animals from the normal and
PCOS groups have been killed at every period of estrous and pro-
estrus cycle, and the ovaries have been harvested for histopathol-
ogy evaluation for the purpose of providing a detailed model
verification. All animals were in the metestrus phase of the sexual
cycle. Vaginal smears showed that the mice were in the metestrus
phase (Fig. 1).
Results of the number of ovarian follicles and ovarian volume
Different control follicles were seen in the ovarian tissue of
mice. Ovaries of the other groups showed variable numbers of
follicles at different developmental stages as well as cystic follicles
with an extremely thin layer of granulosa cells (Fig. 2). No statis-
tically significant difference was observed among the study groups
(P > 0.05) with regard to PMF. The results showed that estradiol
valerate injection for 20 consecutive days (group 2) compared with
the control group (group 1), led to the decrease of PF (P¼ 0.004), an
increase of preantral follicles (P < 0.05), an increase of cystic follicle
(P < 0.05), and the reduction in the number of CL (P < 0.05). Results
reveal that the injection of 0.05 mg/ml retinoic acid dose to healthy
mice (group 3) compared to the control group (group 1) led to the
increase of antral (P < 0.05) and preantral (P ¼ 0.001) follicles. The
injection of FGF2 at a dose of 0.01 mg/kg to healthy mice (group 4)
compared to the control group (group 1) led to an increase of
preantral follicles (P ¼ 0.018) and CL (P ¼ 0.019). The injection of
0.05 mg/ml retinoic acid into polycystic mice (group 5) significantly
increased the preantral follicles and reduced the cystic follicles
(P < 0.05). In group 6, numerous antral follicles and the CL were
increased in comparison with group 2 (P < 0.05and P ¼ 0.001,
respectively), whereas cystic follicles decreased (P < 0.05). In
comparison with group 1 in group 7, the number of preantral,
antral, and CL follicles were increased (P < 0.05), indicating a high
efficacy of concomitant injection of RA and FGF2 into healthy mice
to increase ovarian follicle maturation. Results revealed that
simultaneous injection of RA and FGF2 into polycystic mice (group
8) compared to group 2 led to an increase of antral follicles and CL
and a decrease of cystic follicles (P < 0.05) (Fig. 2). According to
Fig. 3, the ovarian volume has been indicated to be compared be-
tween the RA and FGF2 groups with the PCOS group. The total
volume of ovarian tissue in the treatment groups was remarkably
increased in comparison to the PCOS group (p < 0.01) (Fig. 3). Also,
Fig. 1. The mice metestrus phase shows nucleated epithelial cells (blue arrow), non-nucleated epithelial cells (red arrow), and leukocytes (black arrow).
Fig. 2. Comparison of follicles at different developmental stages in studied groups. In this graph, the asterisk (*) demonstrates a significant difference with group 1 (P < 0.05) and #
sign shows significant difference with groups 2 (P < 0.05).
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control groups. Nonetheless, these results were not significant
(Fig. 3).
Quantitative analysis of follicle and oocyte (diameter and thickness)
The follicular diameter was increased (P < 0.05) in PCOS mice
(group 2) compared to group 1. Results show that either single or
combined injection of RA and FGF2 in groups 5, 6, and 8 signifi-
cantly reduced the follicular diameter compared to group 2
(P ¼ 0.042, P ¼ 0.026, and P ¼ 0.008, respectively) (Fig. 4). The
measurements performed with ImageJ software showed that the
thickness of the epithelium (granulosa cell thickness) was reduced885in group 2 (PCOS-induced) (P < 0.05). Although this thickness in
group 8 (simultaneous injection of RA and FGF2 into polycystic
mice) was significantly increased (P ¼ 0.026), in groups 5 and 6,
single injection had no reversible and therapeutic effects (p > 0.05)
(Fig. 4) (Table 1).
The diameter of the oocyte was reduced (P < 0.05) in PCOS mice
(group 2) compared to group 1. The results showed that oocyte
diameters in groups 4 and 7 were significantly higher than group 1
(P < 0.05). Besides, the results reveal that oocyte diameters were
significantly increased in groups 6 and 8 than in group 2 (P ¼ 0.012
and P ¼ 0.009, respectively), which indicates reversible and ther-
apeutic roles of FGF2 and RA-FGF2, respectively. Theca thickness in
group 2 (PCOS mice) was abnormally increased in comparison to
Fig. 3. Volume study. The effects of administration of RA and FGF2 on the volume of ovary (mm3) of mice with PCOS. **P < 0.01 compared to treatment and control groups.
Fig. 4. Photomicrograph shows antral follicles in different studied groups. Images A (group 1), C (group 3), D (group 4), and G (group 7) represent that follicles are enclosed by a
thick layer of granulosa cells and a normal theca layer. Image B (group 2) indicates that the follicle is enclosed by a thin layer of granulosa cells and a thicker theca layer compared to
the control group and also an increase in the distance between granulosa cell layer and oocyte is observed. Images E (group 5), F (group 6), and H (group 8) show that the theca layer
around the follicle is less thick than the PCOS group and provides better conditions for oocyte release which illustrated the features of a normal follicle image H, Hematoxylin and
eosin (H&E) staining (100 magnification).
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in groups 6 and 8 compared to group 2 (P ¼ 0.35 and P ¼ 0.022,
respectively) (Table 1).Counting of apoptotic cells
Positive TUNEL cell counts indicate that the cell apoptosis in the
antral follicle was determined by ImageJ software. In group 2, the
quantity of positive TUNEL cells has been significantly raised886compared to group 1 (P < 0.05). The number of apoptotic cells
decreased in groups 5, 6, and 8 compared to group 2 (P ¼ 0.035,
P ¼ 0.014, and P ¼ 0.005, respectively) (Fig. 5) (Table 1).Sex hormone measurement
The present study showed that FSH serum in group 2 was lower
compared to the control group, which was significant (P < 0.05).
Results showed that the injection of RA into healthy mice (group 3)
Table 1
Comparison of morphometrical parameters of follicle (or oocyte) and number of apoptotic granulosa cells in studied groups (Mean ± SD).
Groups Granulosa epithelium thickness (mm) Oocyte transverse diameter (mm) Follicle transverse diameter (mm) Theca layer thickness (mm) Apoptotic cells (number)
1 11.48 ± 0.81 70.71 ± 3.1 168.7 ± 5.84 6.44 ± 1.08 2.2 ± 1.4
2 7.1 ± 1.19a 32.6 ± 2.91a 278.9 ± 6.1a 21.4±2a 50 ± 4.1a
3 11.6 ± 1.5 72.6 ± 3.06 164 ± 5.4 6.4 ± 0.96 1.9 ± 1.1
4 11.9 ± 1.1 58 ± 2.82b 170 ± 5.6 6.2 ± 1.54 1.4 ± 0.96
5 7.5 ± 1.08 34 ± 3.22 252±5d 19.4 ± 2.5 43.2 ± 4.2d
6 8.2 ± 1.31 41.8 ± 4.46e 246±6e 14.5 ± 1.7e 35.1 ± 3.17e
7 12.4 ± 1.57 82.2 ± 2.82c 165 ± 5.8 5.8 ± 1.03 1.4 ± 063
8 9 ± 1.33 45.6 ± 3.8f 234 ± 5.1f 13.3±2f 30.4 ± 2.2f
a, b, and c were significantly different to group 1 (P < 0.05); d, e, f were significantly different to group 2 (P < 0.05).
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(P < 0.05), but no significant difference was seen in serum FSH level
in the RA injection group to PCOS mice (group 5) compared to
group 2. In contrast, FGF2 injections into PCOSmice (group 6) led to
an increase of FSH levels (P ¼ 0.016), which indicates an
improvement in hormone levels. ANOVA analysis showed a sig-
nificant increase in serum LH in group 2 in comparison with group
1 (P < 0.05), and in groups 6 and 8, a significant difference has been
observed in comparison with group 2 (P < 0.05). However, no sig-
nificant statistical difference was seen among the other groups.
(P > 0.05) (Fig. 6).
Discussion
According to microscopic observations of ovarian tissue, in-
jections of estradiol valerate tomice lead to cystic follicles, decrease
in antral follicles and CL, increase in LH and decrease FSH, increase
in follicular diameter, decrease in epithelial thickness (decrease inFig. 5. Photomicrograph shows apoptosis of granulosa cells in the ovarian antral follicles. In
of TUNEL staining was measured automatically by ImageJ software. In group 2 (image B), the
A). The decrease in apoptotic cells is seen in groups 5 (image E), 2 (image F), and 3 (image H)
and the corona radiata cells are healthy.
887granulosa cell thickness) and ovarian volume, decrease in oocyte
diameter, and increase in theca thickness. The studies also revealed
that injection of 0.05 mg/ml retinoic acid into healthy mice led to an
increase of preantral and antral follicles and oocyte diameter. The
results showed that both single and combined injection of RA and
FGF2 in groups 5, 6, and 8 significantly reduced follicular diameters
compared to group 2. The measurements showed that the simul-
taneous injection of RA and FGF2 into polycystic mice significantly
led to an increase of antral follicles, CL, epithelial thickness, and
oocyte diameter, and also the reduction of cystic follicles. Positive
TUNEL cells that were significantly increased in the antral follicle of
group 2 considerably decreased in the RA and FGF2 recipient
groups, either alone or in combination. Besides, the injection of
FGF2 to healthy mice at a dose of 0.01 mg/kg led to an increase of
preantral follicles and CL. FGF2 also reduced the follicular theca
thickness in PCOS mice. Since PCOS is an inflammatory process,
factors such as tumor necrosis factor-alpha (TNF-a) are involved in
studies showing that the increase in the theca layer of the follicleorder to determine the level of apoptosis of granulosa cells, the average signal intensity
number of positive TUNEL cells was significantly increased compared to group 1 (image
. According to the data shown in image H, most peripheral granulosa cells are apoptotic
Fig. 6. The graph represents the levels of sex hormones including follicle stimulating hormone (FSH) and luteinizing hormone (LH) in the studied groups. *: significantly differs with
groups 1 (P < 0.05); #: significantly differs with groups 2 (P < 0.05).
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occurs as a result of increased TNF- expression. TNF-a can induce
Cyclooxygenase 2 (COX-2) gene transcription in different ways.
TNF-a in human proliferate luteinizing granulosa cells and rats
induces apoptosis of granulosa cells in the final antral follicles [27].
Fibroblast growth factors can alter the growth, development, and
differentiation of reproductive tissues in different ways. In the fe-
male reproductive system, the effects of this factor are concen-
trated on the ovary in the present study, which indicates that the
FGF2 factor stimulates granular cell production and reduces dif-
ferentiation (reduced steroidogenesis) [28]. Understanding the
relationship between signals that trigger and control the growth of
ovarian follicles will be an essential improvement for the devel-
opment of comprehensive in-vitro and in-vivo maturation tech-
niques; FGF2 is one of which. Initial investigations showed the
location of FGF2 in ovarian follicles and FGF2 receptors in growing
follicles [29]. Studies reveal that the concentration of FGF2 ngmL50
allows the preservation of follicles active in the culture medium for
five days. Given the interaction of RA and FGF2, it is suggested that
RA activates functional receptors for FGF2 in mouse granulosa cells.
FGF2 is effective in enhancing follicle diameter and granulosa cell
proliferation, which was also observed in the present study.
Furthermore, FGF2 stimulates the production of theca cells and
cultured bovine stromal cells [30]. Each ovarian follicle exhibits
specific cellular characteristics associated with its developmental
stage. When the primary follicle contains one layer of granulosa
cells, it still has no receptor for FSH, but since then, the receptors
have appeared on the surface of the follicular cells. When a
developing follicle passes through this stage, its survival and
development depend on extracellular factors (pituitary hormones)
[31], which was similar to the primary follicles in the groups in the
present study. On the other hand, the mechanism of atresia inhi-
bition and cystic follicle formation may be initiated by various
factors such as pituitary surgery, diet disorder, environmental
stressors, and chemicals [32]. Retinoic acid may influence oocyte
maturation by affecting LH or FSH receptor expression of granulosa
cells or may improvemRNA quality and promote oocytematuration
through increased polyadenylation [33]. Pauli et al. (2013) also888reported that increased follicle size correlated with increased levels
of retinol (ROL) and all-trans-retinoic acid (ATRA) levels in follicular
fluid, and ATRA levels in follicles were considerably higher in
healthy women in comparison with women with endometriosis.
From these researchers' views, the presence of ATRA contributes
significantly to the development and quality of oocytes and em-
bryos, and the reduction of that results in IVF failure and infertility
[34]. Retinol and its biological derivative, Retinoic Acid (RA), are
necessary for numerous reproductive processes. ATRA acts by
increasing B cell Lymphoma2 (BCL2) and catalase expression and
reducing the caspase-8 expression and inhibits the apoptosis. The
9-CisRA and ATRA are physiologically active metabolites and nat-
ural components of vitamin A. Many investigations indicated that
oocyte quality is enhanced by retinoic acid through several mech-
anisms such as oocyte protection against oxidative stress, FSH/LH
receptor expression, and TNF-a reduction in oocyte alpha [35,36].
Various growth factors and inducers contribute to the development
of ovarian follicles, and researchers are constantly exploring new
inducers in this field. Jiang et al. indicated that adding fibroblast
growth factors to the culture medium of ovarian granulosa cells
decreased the expression level of mRNA encoding SPRY-3 and
proapoptotic factor Bax. The Western blotting results of their study
showed that FGF activates the ERK1/2 and Akt signaling pathway
rapidly and transiently, thereby increasing the survival rate of
granulosa cells, which play key roles in normal follicle maturation
and egg quality [37]. FGF2 has the highest affinity for receptors. It
causes cell proliferation and migration, protease secretion, and
angiogenesis. Furthermore, FGF2 is capable of activating ribosomal
DNA (rDNA) transcription, and its nuclear accumulation was linked
to cell proliferation. Granulosa cells in the preantral and antral
follicles can produce FGF2 at all stages of follicular development
[38]. Some studies indicated that granulosa cell apoptosis is
inhibited by FGF2. FGF2 induces granulosa cell survival by an un-
known mechanism. However, there is evidence that FGF2 inhibits
apoptosis through both genomic and acute functions. It is sug-
gested that female ovarian volume has been partially and signifi-
cantly affected by RA and FGF2 because of modulating reproductive
endocrine functions and augmenting follicular development or
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normal levels of intracellular free calcium (Ca2þ). In granulosa cells,
FGF2 controls Ca2þ levels through a protein kinase-dependent
mechanism (PKCd). FGF2 involves the plasma membrane calcium
ATPase enzyme (PMCA) to stimulate calcium release. The level of
apoptosis in transgenic mouse granulosa cells was reduced by
overexpression of FGF2. These studies indicate that FGF2 is a
physiological regulator for granulosa cell survival [39,40]. However,
little information is available on their role in oocyte maturation,
ovarian folliculogenesis, and early stages of embryonic develop-
ment [41]. Studies show that adding ATRA to theca cells enhances
DHEA production. Thus, the retinoid family participates in the
biosynthesis of androgens and the expression of steroidogenic
enzymes in normal and PCOS cells [42].
Conclusion
Retinol plays an important role in ovarian steroidogenesis and
female reproduction so that changing retinol to retinaldehyde in-
creases secretion in PCOS cells compared to normal cells. That
suggests that the enzymes responsible for retinol metabolism are
found in single cells and are altered in PCOS individuals. Both RA
and FGF2 could decrease DHEA and testosterone productions in
PCOS thecal cells; therefore, the amount of retinol within the cir-
culatory system in the PCOS model causes retinoid degradation in
the ovaries. In this regard, the alleviation of tissue symptoms by
both FGF2 and RA is probably due to the anti-inflammatory prop-
erties of this product. Finally, injections of RA and FGF2 into PCOS-
induced mice have protective and potential modulator effects,
which could promise new therapies for womenwith PCOS. In order
to understand the signaling pathway and mediator molecules
involving in RA and FGF2 effects in the PCOS model, it is recom-
mended to performmolecular techniques and electronmicroscopic
evaluation.
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Abbreviations
PCOS Polycystic Ovary Syndrome
EV Estradiol Valerate
RA Retinoic Acid
FGF2 Fibroblast Growth Factor-2
CL Corpus Luteum
LH Luteinizing Hormone
FSH Follicle-stimulating Hormone
MMPs Matrix Metallopeptidases
LOX Lysyl Oxidase
ATRA All-trans Retinoic Acid
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H2O2 Hydrogen Peroxide
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